CA Stock MarketDetailed Quotes

PanGenomic Health Inc (NARA)

Watchlist
  • 0.600
  • +0.050+9.09%
15min DelayTrading Jan 16 10:10 ET
15.42MMarket Cap-1.94P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PanGenomic Health Inc (NARA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-9,652.96%-1.47M
-167.74%-159.38K
-377.09%-43.2K
96.29%-58.25K
91.31%-29.67K
113.48%15.35K
83.75%-59.53K
102.09%15.59K
43.65%-1.57M
6.04%-341.21K
Net income from continuing operations
-791.67%-1.76M
84.38%-396.98K
-83.15%-400.63K
-27.95%-3.8M
-52.90%-845.37K
50.63%-197.68K
-164.40%-2.54M
79.33%-218.75K
75.21%-2.97M
94.10%-552.87K
Operating gains losses
----
----
----
7,154.82%2.56M
834.06%272.15K
--0
----
----
-1,491.29%-36.35K
-7,202.30%-37.07K
Depreciation and amortization
-92.57%157
-94.98%157
-94.98%157
-31.29%8.52K
-94.98%157
-32.46%2.11K
0.00%3.13K
3.47%3.13K
11.60%12.4K
5.29%3.13K
Asset impairment expenditure
----
----
----
--0
--0
--0
----
----
-99.02%82.04K
-99.55%37.34K
Remuneration paid in stock
1,813.86%613.39K
-92.81%2.45K
223.28%125.68K
-181.76%-135.97K
-366.63%-240.97K
144.05%32.05K
-60.88%34.07K
-36.90%38.88K
-73.04%166.3K
-54.74%90.37K
Other non cashItems
----
----
----
52.37%67.1K
----
----
----
----
--44.04K
---47.54K
Change In working capital
-282.83%-327.04K
53.19%234.99K
20.41%231.6K
9.28%1.24M
333.57%717.26K
-30.19%178.87K
-67.21%153.4K
-22.10%192.34K
404.96%1.14M
-62.17%165.43K
-Change in receivables
-119.95%-2.5K
--0
77.09%-368
-83.03%11.32K
-98.16%458
379.13%12.53K
-100.15%-61
-137.43%-1.61K
171.26%66.73K
348.20%24.92K
-Change in prepaid assets
---153.46K
--0
57.55%4.97K
-99.39%1.22K
-115.67%-4.97K
--0
-97.54%3.03K
130.82%3.16K
159.33%197.91K
-82.34%31.75K
-Change in payables and accrued expense
-202.85%-171.08K
56.21%234.99K
18.98%227K
41.01%1.23M
563.61%721.78K
-19.88%166.34K
-50.28%150.43K
-24.55%190.79K
259.68%871.78K
-59.35%108.77K
Cash from discontinued investing activities
Operating cash flow
-9,652.96%-1.47M
-167.74%-159.38K
-377.09%-43.2K
96.29%-58.25K
91.31%-29.67K
113.48%15.35K
83.75%-59.53K
102.09%15.59K
43.65%-1.57M
6.04%-341.21K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
93.97%-3.14K
0
Net PPE purchase and sale
----
----
----
--0
--0
--0
--0
--0
47.68%-3.14K
--0
Net business purchase and sale
----
----
----
----
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
--0
--0
--0
--0
93.97%-3.14K
--0
Financing cash flow
Cash flow from continuing financing activities
1.54M
260.62%163.3K
44.33K
-96.86%47K
-99.50%1.72K
0
-87.06%45.28K
0
-5.04%1.5M
-27.35%341.22K
Net issuance payments of debt
---125K
----
----
-95.13%47K
--0
--0
-86.57%47K
--0
581.94%964.4K
146.59%448.92K
Net common stock issuance
---13.51K
874.61%13.3K
--44.33K
--0
101.59%1.72K
--0
---1.72K
--0
-84.22%203.62K
-108.34%-107.7K
Proceeds from stock option exercised by employees
--1.68M
----
----
--0
--0
--0
--0
--0
129.63%327.22K
--0
Cash from discontinued financing activities
Financing cash flow
--1.54M
260.62%163.3K
--44.33K
-96.86%47K
-99.50%1.72K
--0
-87.06%45.28K
--0
-5.04%1.5M
-27.35%341.22K
Net cash flow
Beginning cash position
-54.29%6.36K
-91.34%2.44K
-89.59%1.31K
-85.81%12.56K
133.25%29.26K
277,940.00%13.9K
71.49%28.15K
-85.81%12.56K
-93.44%88.53K
-55.39%12.54K
Current changes in cash
393.74%75.81K
127.49%3.92K
-92.74%1.13K
85.19%-11.25K
-164,505.88%-27.95K
22.46%15.35K
13.18%-14.25K
121.62%15.59K
93.97%-75.97K
-99.97%17
End cash Position
180.84%82.16K
-54.29%6.36K
-91.34%2.44K
-89.59%1.31K
-89.59%1.31K
133.25%29.26K
277,940.00%13.9K
71.49%28.15K
-85.81%12.56K
-85.81%12.56K
Free cash from
-9,652.96%-1.47M
-167.74%-159.38K
-377.09%-43.2K
96.29%-58.25K
91.31%-29.67K
113.48%15.35K
83.75%-59.53K
102.08%15.59K
43.66%-1.57M
6.04%-341.21K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -9,652.96%-1.47M-167.74%-159.38K-377.09%-43.2K96.29%-58.25K91.31%-29.67K113.48%15.35K83.75%-59.53K102.09%15.59K43.65%-1.57M6.04%-341.21K
Net income from continuing operations -791.67%-1.76M84.38%-396.98K-83.15%-400.63K-27.95%-3.8M-52.90%-845.37K50.63%-197.68K-164.40%-2.54M79.33%-218.75K75.21%-2.97M94.10%-552.87K
Operating gains losses ------------7,154.82%2.56M834.06%272.15K--0---------1,491.29%-36.35K-7,202.30%-37.07K
Depreciation and amortization -92.57%157-94.98%157-94.98%157-31.29%8.52K-94.98%157-32.46%2.11K0.00%3.13K3.47%3.13K11.60%12.4K5.29%3.13K
Asset impairment expenditure --------------0--0--0---------99.02%82.04K-99.55%37.34K
Remuneration paid in stock 1,813.86%613.39K-92.81%2.45K223.28%125.68K-181.76%-135.97K-366.63%-240.97K144.05%32.05K-60.88%34.07K-36.90%38.88K-73.04%166.3K-54.74%90.37K
Other non cashItems ------------52.37%67.1K------------------44.04K---47.54K
Change In working capital -282.83%-327.04K53.19%234.99K20.41%231.6K9.28%1.24M333.57%717.26K-30.19%178.87K-67.21%153.4K-22.10%192.34K404.96%1.14M-62.17%165.43K
-Change in receivables -119.95%-2.5K--077.09%-368-83.03%11.32K-98.16%458379.13%12.53K-100.15%-61-137.43%-1.61K171.26%66.73K348.20%24.92K
-Change in prepaid assets ---153.46K--057.55%4.97K-99.39%1.22K-115.67%-4.97K--0-97.54%3.03K130.82%3.16K159.33%197.91K-82.34%31.75K
-Change in payables and accrued expense -202.85%-171.08K56.21%234.99K18.98%227K41.01%1.23M563.61%721.78K-19.88%166.34K-50.28%150.43K-24.55%190.79K259.68%871.78K-59.35%108.77K
Cash from discontinued investing activities
Operating cash flow -9,652.96%-1.47M-167.74%-159.38K-377.09%-43.2K96.29%-58.25K91.31%-29.67K113.48%15.35K83.75%-59.53K102.09%15.59K43.65%-1.57M6.04%-341.21K
Investing cash flow
Cash flow from continuing investing activities 0000093.97%-3.14K0
Net PPE purchase and sale --------------0--0--0--0--047.68%-3.14K--0
Net business purchase and sale ----------------------------------0----
Cash from discontinued investing activities
Investing cash flow --------------0--0--0--0--093.97%-3.14K--0
Financing cash flow
Cash flow from continuing financing activities 1.54M260.62%163.3K44.33K-96.86%47K-99.50%1.72K0-87.06%45.28K0-5.04%1.5M-27.35%341.22K
Net issuance payments of debt ---125K---------95.13%47K--0--0-86.57%47K--0581.94%964.4K146.59%448.92K
Net common stock issuance ---13.51K874.61%13.3K--44.33K--0101.59%1.72K--0---1.72K--0-84.22%203.62K-108.34%-107.7K
Proceeds from stock option exercised by employees --1.68M----------0--0--0--0--0129.63%327.22K--0
Cash from discontinued financing activities
Financing cash flow --1.54M260.62%163.3K--44.33K-96.86%47K-99.50%1.72K--0-87.06%45.28K--0-5.04%1.5M-27.35%341.22K
Net cash flow
Beginning cash position -54.29%6.36K-91.34%2.44K-89.59%1.31K-85.81%12.56K133.25%29.26K277,940.00%13.9K71.49%28.15K-85.81%12.56K-93.44%88.53K-55.39%12.54K
Current changes in cash 393.74%75.81K127.49%3.92K-92.74%1.13K85.19%-11.25K-164,505.88%-27.95K22.46%15.35K13.18%-14.25K121.62%15.59K93.97%-75.97K-99.97%17
End cash Position 180.84%82.16K-54.29%6.36K-91.34%2.44K-89.59%1.31K-89.59%1.31K133.25%29.26K277,940.00%13.9K71.49%28.15K-85.81%12.56K-85.81%12.56K
Free cash from -9,652.96%-1.47M-167.74%-159.38K-377.09%-43.2K96.29%-58.25K91.31%-29.67K113.48%15.35K83.75%-59.53K102.08%15.59K43.66%-1.57M6.04%-341.21K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +5.38%
Sample Name
Sample Code
 +2.09%
Sample Name
Sample Code
 +1.44%
4
Tempus AI
TEM
+1.36%
5
Warner Bros Discovery
WBD
+0.86%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -